{
    "2019-09-26": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Citi Bullish On AbbVie As Allergan Deal Provides An Earnings Floor",
                "features": {
                    "keywords": [
                        "Citi",
                        "Bullish",
                        "AbbVie",
                        "Allergan",
                        "Earnings Floor"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "6 Declining Stocks in Gurus' Portfolios",
                "features": {
                    "keywords": [
                        "Declining Stocks",
                        "Gurus",
                        "Portfolios"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Is Up After Another Analyst Reconsidered Its Allergan Acquisition and Upgraded the Stock",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Up",
                        "Analyst",
                        "Allergan",
                        "Acquisition",
                        "Upgraded"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Enanta",
                        "NASH",
                        "Takeda",
                        "Ulcerative Colitis",
                        "AbbVie",
                        "J&J"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "[video]AbbVie Stock Gains on Citi Upgrade to Buy and Price-Target Boost",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock Gains",
                        "Citi",
                        "Upgrade",
                        "Price-Target Boost"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}